Graypoint LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Graypoint LLC's AMGN Position: Q2 2025 in Review
Graypoint LLC reduced its Amgen (AMGN) stake by 31% in Q2 2025, selling an estimated $693K and leaving 5,413 shares worth $1.51M. The position accounts for 0.09% of the portfolio, ranked #160.
Graypoint LLC first reported a position in AMGN in Q3 2020 and has held it in 20 quarters since. The position peaked at $2.45M in Q1 2025. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- Graypoint LLC held 5,413 shares of Amgen worth $1.51M as of Q2 2025.
- Graypoint LLC sold 2,446 Amgen shares in Q2 2025, an estimated $693K.
- Amgen made up 0.09% of Graypoint LLC's portfolio in Q2 2025, its #160 holding.
- Graypoint LLC first reported a position in Amgen in Q3 2020 and has held it in 20 quarters since.
- Graypoint LLC's Amgen position peaked at $2.45M in Q1 2025.
- 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.